Fosgemcitabine palabenamide

DB15057InvestigationalSmall molecule

NUC-1031 is under investigation in clinical trial NCT03610100 (Acelarin First Line Randomised Pancreatic Study).

Chemical structure of Fosgemcitabine palabenamide
Mechanism
Curator reviewed
Formula / weight
C25H27F2N4O8P · 580.482 g/mol (avg)
Code names
BIO-1031 · NUC-1031 · NUC-1031, (S)-

Resolves to

Structure
InChIKeyNHTKGYOMICWFQZ-UHFFFAOYSA-NSMILESCC(NP(=O)(OCC1OC(N2C=CC(N)=NC2=O)C(F)(F)C1O)OC1=CC=CC=C1)C(=O)OCC1=CC=CC=C1
Targets

What you can answer from here — as of October 11, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Fosgemcitabine palabenamide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account